EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter randomized comparative study of radical prostatectomy versus 3 and 6 months of neoadjuvant hormonal therapy prior to radical prostatectomy in stage B and C prostate cancer



Multicenter randomized comparative study of radical prostatectomy versus 3 and 6 months of neoadjuvant hormonal therapy prior to radical prostatectomy in stage B and C prostate cancer



Journal of Urology 163(4 Suppl ): 292, April




(PDF 0-2 workdays service: $29.90)

Accession: 035349894

Download citation: RISBibTeXText



Related references

Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. The European Study Group on Neoadjuvant Treatment of Prostate Cancer. Urology 49(3a Suppl): 65-69, 1997

Randomized comparative study of 3 vs 8 months of neoadjuvant hormonal therapy prior to radical prostatectomy 3 year PSA recurrence rates. Journal of Urology 169(4 Supplement): 179, April, 2003

Randomized comparative study of 3 VS 8 months of neoadjuvant hormonal therapy prior to radical prostatectomy Biochemical and pathological effects. Journal of Urology 161(4 SUPPL ): 154, April, 1999

Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. The Lupron Depot Neoadjuvant Prostate Cancer Study Group. Journal of Urology 154(2 Pt 1): 424-428, 1995

Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T23 N0 M0 prostatic carcinoma. Urology 49(3-Supp-S1): 65-69, 1997

Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T-2-3 N-o M-o prostatic carcinoma. Urology 49(SUPPL 3A): 65-69, 1997

A prospective randomised study comparing immediate radical prostatectomy to a 3 or 6 months neoadjuvant hormonal treatment preceeding radical prostatectomy, in clinical T1-T2 prostate cancers. European Urology 39(Suppl 5): 137, March, 2001

4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Urology 38(6): 706-713, December, 2000

4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Study Group on Neoadjuvant Treatment of Prostate Cancer. European Urology 38(6): 706-713, 2000

Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer. Journal of Urology 154(2): 424-428, 1995

Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. Journal of Urology 154(2 PART 1): 424-428, 1995

Neoadjuvant hormonal treatment with triptorelin versus no treatment prior to radical prostatectomy A prospective randomized multicenter study. Journal of Urology 153(4 SUPPL ): 391A, 1995

Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: Biochemical and pathological effects. Journal of Urology 166(2): 500-507, August, 2001

Effects of three months neoadjuvant hormonal treatment with a GnRH-analogue prior to radical prostatectomy on PSA and tumor volume in prostate cancer. Scandinavian Journal of Urology & Nephrology Supplementum 0(151): 31-32, 1993

Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. The Belgian Uro-Oncological Study Group. Journal of Urology 154(2 Pt 1): 429-434, 1995